BioMed Technology Holdings
Units 311-312, 3/F, Building 16W, No.16 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong
Overview
BioMed Technology Holdings, founded in 2018, is a Hong Kong-based firm that operates the probiotic health supplement brand PGut and provides microbiome health management solutions. Its offerings include microbiome DNA testing, tailor-made probiotic products, and dietary recommendations aimed at improving physical and mental health. The company plans to expand into the pet healthcare market, partnering with local veterinary group PetSpace to conduct a large-scale research project involving 500 felines and canines. It is also collaborating with PSG Vivet to develop gut microbiome tests and personalised probiotics for pets, with a pet healthcare product line expected to launch in Q3 this year. Financially, BioMed recently raised an undisclosed investment from CUHK Innovation, the investment vehicle wholly owned by the Chinese University of Hong Kong. Previously it sealed a $2 million oversubscribed seed round in April 2023 from Alibaba Hong Kong Entrepreneurs Fund, Gobi Partners GBA and The International Medical. BioMed Technology Holdings, founded in 2018 and a partner company of Hong Kong Science and Technology Parks Corporation, develops microbiome DNA testing and personalised microbiome health management solutions. Its core offerings combine microbiome DNA testing with tailored product recommendations and the PGut brand of pre+pro+postbiotics. The company has partnerships with over 100 healthcare service providers, a microbiome database of more than 10,000 profiles, and PGut distribution across 300+ retail outlets. R&D is expanding beyond the gut to include oral and skin microbiomes as part of a total microbiome solution. BioMed is shifting some operations from B2B toward B2C in markets such as Thailand and plans lab/premises setup in Shenzhen plus GMP manufacturing and product development in Japan. The company positions itself on precision, personalised microbiome interventions for wellness and disease prevention rather than conventional one‑size‑fits‑all supplements.
- Total raised
- $2M
- Funding rounds
- 2
- Latest round
- Seed
- Latest activity
- Apr 2023
Industries
- Biotechnology
- Hospitality
- Market Research
- Medical
Recent funding
Seed
Apr 2023
$2M
Team
No current team members are available.